These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 22882176

  • 1. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus.
    Bärnighausen T, Bloom DE, Cafiero ET, O'Brien JC.
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():70-6. PubMed ID: 22882176
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M.
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB, Mendoza LO, García O, Díaz I, Figueroa J, Duarte RM, Perdomo G, Garcia AG, Janusz CB.
    Vaccine; 2015 May 07; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Implementation of human papillomavirus immunization in the developing world.
    Kane MA, Serrano B, de Sanjosé S, Wittet S.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A.
    Vaccine; 2010 Nov 29; 28(51):8065-72. PubMed ID: 20971114
    [Abstract] [Full Text] [Related]

  • 8. Introduction of human papillomavirus vaccination in Nordic countries.
    Sander BB, Rebolj M, Valentiner-Branth P, Lynge E.
    Vaccine; 2012 Feb 14; 30(8):1425-33. PubMed ID: 22154773
    [Abstract] [Full Text] [Related]

  • 9. The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.
    Setiawan D, Luttjeboer J, Westra TA, Wilschut JC, Suwantika AA, Daemen T, Atthobari J, Wilffert B, Postma MJ.
    Expert Rev Vaccines; 2015 Apr 14; 14(4):589-604. PubMed ID: 25482311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Methodological aspects of clinical and economic impact of vaccine interventions and HTA. Focus on HPV vaccination].
    Ricciardi W, Dirodi B, Bonanni P, Capri S, Castiglia P, Gabutti G, Gasparini R, Giorgi Rossi P, Grilli G, La Torre G.
    Ann Ig; 2011 Apr 14; 23(5):419-34. PubMed ID: 22403995
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
    Westra TA, Daemen T, Postma MJ, Wilschut JC.
    Ned Tijdschr Geneeskd; 2009 Apr 14; 153():A356. PubMed ID: 19930733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
    Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S, Kiss I, Ember I, Gocze P.
    Vaccine; 2011 Nov 03; 29(47):8591-8. PubMed ID: 21939711
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus, cancer and vaccination.
    Heard I.
    Curr Opin HIV AIDS; 2011 Jul 03; 6(4):297-302. PubMed ID: 21519247
    [Abstract] [Full Text] [Related]

  • 17. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M.
    Cancer; 2007 Jun 25; 111(3):145-53. PubMed ID: 17487850
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER.
    Am J Obstet Gynecol; 2008 May 25; 198(5):487-8. PubMed ID: 18455522
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    de Kok IM, van Ballegooijen M, Habbema JD.
    J Natl Cancer Inst; 2009 Aug 05; 101(15):1083-92. PubMed ID: 19571256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.